UCSD PIs Secure $4m in CIRM Funding to Advance Stem Cell-based Therapies Targeting Cancers & ALS

UCSD PIs Secure $4m in CIRM Funding to Advance Stem Cell-based Therapies Targeting Cancers & ALS

The University of California San Diego (UCSD) School of Medicine received $4 million thanks to the California Institute for Regenerative Medicine (CIRM) to advance studies using new stem-cell-based treatments for multiple types of cancer and amyotrophic lateral sclerosis (ALS). Announced August 24, 2021, the funds are directed to three regenerative research initiatives, including 1) $1.4 million to develop a new chimeric antigen receptor (CAR-T) therapy for treating or drug-resistant malignancies such as ovarian cancer; 2) $1.1. million to develop new therapies for directing the migration of target-specific therapeutic stem cells; and 3) $1.2 million to develop a small molecule inhibitor that blocks the growth of cells that drive human pancreatic cancer and acute myeloid leukemia.

TrialSite provides a breakdown of the funder—CIRM, the principal investigators, and the research’s importance.

Regenerative Research Funding

The California Institute for Regenerative Medicine (CIRM) was born thanks to California voters approval of Proposition 71, known as the Research and Cures Initiative in 2004, when 59% of the voters in the Golden State authorized a law that, among other...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee